Navigation Links
Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
Date:2/13/2013

LA JOLLA, Calif., Feb. 13, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights for the fourth quarter and year ended December 31, 2012 on Wednesday, February 20, 2013, after the U.S. financial markets close.

Regulus will host a conference call and webcast on Wednesday, February 20, 2013 at 5:00 pm Eastern Standard Time to discuss its fourth quarter and year-end 2012 financial results, recent company highlights and its expectations for 2013. A live webcast of the call will be available online at www.regulusrx.com.  To access the telephone replay of the call, dial (855) 859-2056 (domestic) or (404) 537-3406 (international), passcode 10388595. The webcast and telephone replay will be archived on the company's website for two weeks following the call. 

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad network of academic collaborators and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals and Isis Pharmaceuticals. Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more information, please visit http://w
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regulus to Present at Two Upcoming Investor Conferences
2. Regulus Appoints Mark G. Foletta to its Board of Directors
3. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
4. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
5. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
6. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
7. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
8. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
9. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
10. CryoLife Announces Quarterly Cash Dividend for the First Quarter 2013
11. Xenon Announces Appointment of EVP, Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 ... it will release its second quarter 2015 financial results ... 2015.   In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... regarding the notice it received on May 21, 2015 ... the Company was below certain of the Exchange,s continued ... 1101 of the NYSE MKT Company Guide, due to ...
Breaking Medicine Technology:IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... 24, 2011 Apelon, Inc., a leading ... today announced the availability of the first ... code set management and collaborative mapping application, ... enabling widespread access to national healthcare vocabulary ...
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ), ... extracellular matrix , for the diabetes, cancer, dermatology ... presentation for PEGPH20 at the 2011 EORTC-NCI-ASCO Annual Meeting, ... is a PEGylated form of rHuPH20 that is being ...
Cached Medicine Technology:Apelon Announces Availability of New TermManager® Software 2Halozyme Therapeutics to Present Data on PEGPH20 at the Upcoming 2011 EORTC-NCI-ASCO Annual Meeting 2
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, ... has re-branded their social media profiles to better connect with the public. The ... communicate, find information, share insights and opinions. The Rally Insurance Group, Inc.’s pledge ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source of authentic Hamilton tickets at ... show on Broadway, look no further than Hamilton. This American musical is critically acclaimed ... Award, Drama Desk Award, Lucille Lortel Award, and New York Drama Critics’ Award. The ...
(Date:7/31/2015)... ... 2015 , ... Well-known for its unique pastries and delicious confections, Pastry Palace, ... designs, making life just a little bit sweeter for newlyweds. A family-owned business, the ... orders one. , The bakery provides a full line of custom wedding cakes. Brides ...
(Date:7/31/2015)... ... , ... As part of their company mission, Dallas pet sitting company ... is essential to the longevity of their business. It is for that reason ... Pet Sitters (NAPPS) annual Presents 4 Pets supply drive. Presents 4 Pets ...
(Date:7/31/2015)... ... July 31, 2015 , ... Creating one of the most modern ... of a visionary image that goes beyond the boundaries of fertility medicine. , ... reached extraordinary heights with dependable patient support, affordable treatments, unending hope, and high fertility ...
Breaking Medicine News(10 mins):Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3
... Association (AGA) Foundation for Digestive Health and Nutrition (FDHN) ... Foundation Research Scholar Award Kenneth P. Olive, PhD. ... will provide Dr. Olive with funding and protected time ... to pancreatic cancer. Mr. Schwartz, a businessman and photographer, ...
... show way to stop breast tumors in their tracks, scientists ... of the element selenium, which is found in tiny amounts ... after it has been thrown off by cancer-causing chemicals, researchers ... lead to a way to help the body reboot cells ...
... Using a new mouse model of Alzheimer,s disease, researchers at ... originates in Amyloid-Beta (Abeta) oligomers in the brain, rather than ... the disease. The study, which was supported ... and a MERIT Award from the Veterans Administration, appears in ...
... ... time-consuming entry themselves , ... Fitchburg, WI (Vocus) April 27, 2010 -- Emdat announces the launch ... of electronic medical records by seamlessly integrating with Emdat,s online medical transcription platform. , ...
... by Danish researchers discovered patients with alcoholic cirrhosis had ... the disease diagnosis. Researchers noted that complications, such ... of mortality, but did not develop in a predictable ... in the May issue of Hepatology , a ...
... oil that is spilling into the Gulf of Mexico after a ... Mississippi, USA, on 22 April. In the black-and-white radar image ... the bottom right, while in the optical image it is seen ... and the Delta National Wildlife Refuge extends out into the Gulf. ...
Cached Medicine News:Health News:Second AGA Foundation/Bernard Lee Schwartz Foundation Research Scholar Award presented 2Health News:Selenium Helped Cells 'Reboot' After Exposure to Cancer-Causing Chemicals 2Health News:Alzheimer's memory problems originate with protein clumps floating in the brain, not amyloid plaques 2Health News:Emdat Launches DaRT Solution That Allows Physicians to Use EMRs with No Changes to Daily Workload 2Health News:Alcoholic cirrhosis patients had high prevalence of complications at diagnosis 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: